⚠️ Capex Efficiency Concern Trishakti's ₹210 Cr investment generates only ₹6 Cr incremental revenue—a concerning 2.9% Year 1 return. While long-term capacity expansion offers competitive positioning upside, near-term margin compression is inevitable due to elevated depreciation outpacing revenue gains. EBITDA margin pressure in FY27 likely precedes recovery if utilization exceeds 70%. Critical unknowns: funding structure, actual payback period, and phased revenue visibility. Monitor execution rigorously; current metrics suggest modest efficiency gains absent accelerated capacity ramp-up.

⚠️ Capex Efficiency Concern Trishakti's ₹210 Cr investment generates only ₹6 Cr incremental revenue—a concerning 2.9% Year 1 return. While long-term capacity expansion offers competitive positioning upside, near-term margin compression is inevitable due to elevated depreciation outpacing revenue gains. EBITDA margin pressure in FY27 likely precedes recovery if utilization exceeds 70%. Critical unknowns: funding structure, actual payback period, and phased revenue visibility. Monitor execution rigorously; current metrics suggest modest efficiency gains absent accelerated capacity ramp-up.

⚠️ Capex Efficiency Concern Trishakti's ₹210 Cr investment generates only ₹6 Cr incremental revenue—a concerning 2.9% Year 1 return. While long-term capacity expansion offers competitive positioning upside, near-term margin compression is inevitable due to elevated depreciation outpacing revenue gains. EBITDA margin pressure in FY27 likely precedes recovery if utilization exceeds 70%. Critical unknowns: funding structure, actual payback period, and phased revenue visibility. Monitor execution rigorously; current metrics suggest modest efficiency gains absent accelerated capacity ramp-up.

⚠️ Capex Efficiency Concern Trishakti's ₹210 Cr investment generates only ₹6 Cr incremental revenue—a concerning 2.9% Year 1 return. While long-term capacity expansion offers competitive positioning upside, near-term margin compression is inevitable due to elevated depreciation outpacing revenue gains. EBITDA margin pressure in FY27 likely precedes recovery if utilization exceeds 70%. Critical unknowns: funding structure, actual payback period, and phased revenue visibility. Monitor execution rigorously; current metrics suggest modest efficiency gains absent accelerated capacity ramp-up.